Jove
Visualize
Contact Us

Related Experiment Videos

Erythromycin.

D C Brittain1

  • 1Health Science Center, State University of New York, Syracuse.

The Medical Clinics of North America
|November 1, 1987
PubMed
Summary
This summary is machine-generated.

Erythromycin, a macrolide antibiotic, remains a top choice for specific infections due to its effectiveness and safety. Despite newer antibiotics, its unique activity against certain pathogens ensures its continued clinical importance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fast food arthritis--a clinico-pathologic study of post-Salmonella reactive arthritis.

The Journal of rheumatology·1995
Same author

In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone.

Antimicrobial agents and chemotherapy·1986
Same author

Ticarcillin plus clavulanic acid in the treatment of pneumonia and other serious infections.

The American journal of medicine·1985
Same author

The pharmacokinetic and bactericidal characteristics of oral cefixime.

Clinical pharmacology and therapeutics·1985
Same author

The pharmacokinetics and serum and urine bactericidal activity of ciprofloxacin.

Journal of clinical pharmacology·1985
Same author

The pharmacology of orally administered ciprofloxacin.

Drugs under experimental and clinical research·1985
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Erythromycin, a macrolide antibiotic, has been widely used since 1952.
  • Numerous antibiotics have been developed since erythromycin's introduction.
  • Newer antibiotics often possess broader antimicrobial spectra.

Purpose of the Study:

  • To highlight the enduring clinical significance of erythromycin.
  • To explain why erythromycin remains a first-choice antibiotic despite newer alternatives.
  • To emphasize the safety and effectiveness of erythromycin.

Main Methods:

  • This is a review of existing literature and clinical data.
  • The study analyzes the historical usage and current standing of erythromycin.
  • Comparative analysis of erythromycin against newer antimicrobial agents is discussed.

Related Experiment Videos

Main Results:

  • Erythromycin maintains its position as a primary treatment for specific pathogens.
  • Newer antibiotics, despite broader spectra, are ineffective against certain organisms targeted by erythromycin.
  • Erythromycin is recognized as one of the safest available antibiotics.

Conclusions:

  • Erythromycin's unique efficacy against specific pathogens secures its role in clinical practice.
  • The drug's established safety profile and effectiveness in indicated situations are key factors.
  • Erythromycin remains an indispensable antibiotic in the clinician's armamentarium.